Table 3 Interleukin and analysis of oxidative stress in cardiac tissue. CTL–Control, MetS–Metabolic Syndrome, MetS+O–Metabolic Syndrome and Okra, MetS+ET–Metabolic Syndrome and Exercise Training, MeTS + ET + O–Metabolic Syndrome and Exercise Training and Okra. IL–10–Interleukin −10, IL–6–Interleukin–6, TNF–α–Tumor Necrosis Factor Alpha, MDA–Malondialdehyde, TAS–Total Antioxidant Status, TOS–Total Oxidant Status, OSI–Oxidative Stress Index. *Different from CTL, #Different from MetS. p ≤ 0.05.

IL–10 (pg/µg)

191.1 (± 44.6)

52.2 (± 35.8)*

55.7 (± 17.9)*

34.6 (± 8.0)*

32.9 (± 28.6)*

IL–6 (pg/µg)

67.9 (± 8.0)

84.7 (± 27.5)

28.4 (± 8.0)^#

37.3 (± 22.6)

45.5 (± 24.8)

TNF–α (pg/µg)

41.0 (± 13.6)

40.5 (± 10.1)

42.8 (± 7.2)

35.8 (± 12.0)

49.3 (± 12.1)

MDA nm (UI)

1.2 (± 0.1)

1.2 (± 0.1)

1.3 (± 0.2)

1.42 (± 0.2)

1.4 (± 0.2)

TAS (mmol Trolox equ./L)

1.4 (± 0.0)

1.6 (± 0.0)

1.4 (± 0.2)

1.7 (± 0.1)

1.5 (± 0.1)

TOS (mmol H₂O₂ equ./L)

10.9 (± 0.0)

11.0 (± 0.2)

10.9 (± 0.1)

10.9 (± 0.0)

10.7 (± 0.3)

OSI (TOS/TAS)

7.3 (± 0.3)

6.82 (± 0.4)

6.9 (± 0.6)

6.4 (± 0.3)

7.0 (± 0.7)